Skin, gut, and lung barrier: Physiological interface and target of intervention for preventing and treating allergic diseases
Allergy · 2024-06 · 79 (6) · 1485-1500
DOI: 10.1111/all.16092 ↗At a glance
Übersichtsarbeit in Allergy, published online on 2024-03-04. Written by Roberto Berni Canani and 3 co-authors. Institution: Department of Translational Medical Science, University of Naples Federico II, Naples, Italy. Major MEDLINE topics: Hypersensitivity. Cited 87 times so far (Crossref); 208 references. The full text is freely available (open access, CC BY 4.0). Funded by: Amgen, AstraZeneca.
Abstract (original language)
The epithelial barriers of the skin, gut, and respiratory tract are critical interfaces between the environment and the host, and they orchestrate both homeostatic and pathogenic immune responses. The mechanisms underlying epithelial barrier dysfunction in allergic and inflammatory conditions, such as atopic dermatitis, food allergy, eosinophilic oesophagitis, allergic rhinitis, chronic rhinosinusitis, and asthma, are complex and influenced by the exposome, microbiome, individual genetics, and epigenetics. Here, we review the role of the epithelial barriers of the skin, digestive tract, and airways in maintaining homeostasis, how they influence the occurrence and progression of allergic and inflammatory conditions, how current treatments target the epithelium to improve symptoms of these disorders, and what the unmet needs are in the identification and treatment of epithelial disorders.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Translational Medical Science, University of Naples Federico II, Naples, Italy.
- CEINGE Advanced Biotechnologies, University of Naples Federico II, Naples, Italy.
- Allergy Unit and Asthma Centre, Verona Integrated University Hospital and Department of Medicine, University of Verona, Verona, Italy.
- Allergy Unit, Hospital Regional Universitario de Malága, Malaga, Spain.
- Allergy Group, Biomedical Research Institute of Malaga (IBIMA)-BIONAND Platform, RICORS Inflammatory Diseases, Malaga, Spain.
ORCID profiles: Roberto Berni Canani, Marco Caminati, Laura Carucci, Ibon Eguiluz-Gracia
Funding
- Amgen
- AstraZeneca
Cite
APA
Berni Canani, R., Caminati, M., Carucci, L., & Eguiluz-Gracia, I. (2024). Skin, gut, and lung barrier: Physiological interface and target of intervention for preventing and treating allergic diseases. Allergy, 79(6), 1485-1500. https://doi.org/10.1111/all.16092
Vancouver
Berni Canani R, Caminati M, Carucci L, Eguiluz-Gracia I. Skin, gut, and lung barrier: Physiological interface and target of intervention for preventing and treating allergic diseases. Allergy. 2024;79(6):1485-1500. doi:10.1111/all.16092
BibTeX
@article{BerniCanani2024,
author = {Berni Canani, Roberto and Caminati, Marco and Carucci, Laura and Eguiluz-Gracia, Ibon},
title = {Skin, gut, and lung barrier: Physiological interface and target of intervention for preventing and treating allergic diseases},
journal = {Allergy},
year = {2024},
volume = {79},
number = {6},
pages = {1485--1500},
doi = {10.1111/all.16092}
}
EUVIMED